Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (MX2018006779) TERAPIA CICLICA CON 3-(5-AMINO-2-METIL-4-OXO-4H-QUINAZOLIN-3-IL)-P IPERIDIN-2,6-DIONA.

Office : Mexico
Application Number: 2018006779 Application Date: 01.06.2018
Publication Number: 2018006779 Publication Date: 01.08.2018
Publication Kind : A
IPC:
A61K 31/517
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
517
ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
CPC:
A61K 31/517
A61K 9/0053
A61P 35/00
Applicants: CELGENE CORPORATIONCELGENE CORPORATION
Inventors: Anita GANDHI
Patrick HAGNER
Michael POURDEHNAD
Priority Data: 62/262,263 02.12.2015 US
Title: (ES) TERAPIA CICLICA CON 3-(5-AMINO-2-METIL-4-OXO-4H-QUINAZOLIN-3-IL)-P IPERIDIN-2,6-DIONA.
Abstract:
(EN) Provided herein are methods of treating, preventing and/or managing cancer, including lymphoma, which comprise administering to a patient 3-(5-amino-2-methyl-4- oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in a cyclic therapy regimen.
Also published as:
AU2016364753CA3006758SG11201804367PIL259597EP3383398KR1020180088401
BR112018010964EA201891289WO/2017/096024